| Financial Year |
September 30 2020 |
| Monetary Funds |
905,294,180.79 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
978,498,198.55 |
| Accounts Receivable |
1,472,749,822.14 |
| Advances to Suppliers |
54,179,534.51 |
| Other Receivables |
5,456,626.97 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
420,666,673.66 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
50,352,356.35 |
| Total Current Assets |
3,887,197,392.97 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
2,759,273.33 |
| Fixed Assetes |
1,240,542,998.82 |
| Under-construction Projects |
29,070,741.21 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
121,982,893.34 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,199,295.87 |
| Deferred Income Tax Assets |
5,193,599.13 |
| Other Non-Current Assets |
9,603,100.00 |
| Sub-Total of Non-Current Assets |
1,412,351,901.70 |
| Total Assets |
5,299,549,294.67 |
| Short-Term Loans |
820,601,277.78 |
| Trading Financial liabilities |
-- |
| Notes Payable |
996,926,765.67 |
| Accounts Payable |
948,143,026.68 |
| Accounts Received In Advance |
52,377,867.10 |
| Employee Compensation Payable |
20,340,101.38 |
| Taxes Payable |
25,678,164.06 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
218,036,893.41 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
31,820,000.00 |
| Other Current Liabilities |
99,835,528.92 |
| Sub-Total of Current Liabilities |
3,213,759,625.00 |
| Long-term Loans |
183,637,393.25 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
306,259,296.22 |
| Total Liabilities |
3,520,018,921.22 |
| Paid-In Capital(Or Share Stock) |
235,000,000.00 |
| Capital Surplus |
190,111,836.26 |
| Surplus Reserve |
74,650,762.39 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
929,760,827.41 |
| Minority Stockholder's Interest |
349,349,853.41 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,430,180,520.04 |
| Owner's Equity（Stockholder's Equity） |
1,779,530,373.45 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,299,549,294.67 |
